ArticleSensors (Basel, Switzerland)2023
Tail Artifact Removal via Transmittance Effect Subtraction in Optical Coherence Tail Artifact Images.
Article in Sensors (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Optical Coherence Tomography Angiography (OCTA) has revolutionized non-invasive, high-resolution imaging of blood vessels. However, the challenge of tail artifacts in OCTA images persists. In response, we present the Tail Artifact Removal via Transmittance Effect Subtraction (TAR-TES) algorithm that effectively mitigates these artifacts. Through a simple physics-based model, the TAR-TES accounts for variations in transmittance within the shallow layers with the vasculature, resulting in the removal of tail artifacts in deeper layers after the vessel. Comparative evaluations with alternative correction methods demonstrate that TAR-TES excels in eliminating these artifacts while preserving the essential integrity of vasculature images. Crucially, the success of the TAR-TES is closely linked to the precise adjustment of a weight constant, underlining the significance of individual dataset parameter optimization. In conclusion, TAR-TES emerges as a powerful tool for enhancing OCTA image quality and reliability in both clinical and research settings, promising to reshape the way we visualize and analyze intricate vascular networks within biological tissues. Further validation across diverse datasets is essential to unlock the full potential of this physics-based solution.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.